항균제 감수성 시험 시장 규모, 점유율, 성장 분석 : 제품별, 유형별, 방법별, 용도별, 최종사용자별, 지역별 - 산업 예측(2026-2033년)

Antimicrobial Susceptibility Testing Market size was valued at USD 4.63 Billion in 2024 and is poised to grow from USD 4.87 Billion in 2025 to USD 7.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The antimicrobial susceptibility testing (AST) market is integral to healthcare, particularly in managing infectious diseases and advancing microbiology. Driving factors include the escalating prevalence of antibiotic-resistant bacteria and a global surge in infectious diseases, which heightens the demand for accurate diagnostic technologies. Innovations like automation and molecular methods are enhancing AST precision and effectiveness. The growing number of market players also presents diverse testing options for healthcare providers. However, challenges such as high costs of AST technologies, lack of standardization, and procedural complexities may hinder market growth, particularly in lower-income regions. Nonetheless, the increasing trend towards point-of-care testing, along with advancements in regenerative medicine, opens opportunities for more user-friendly AST solutions and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The escalating issue of antimicrobial resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to prioritize robust antimicrobial susceptibility testing (AST) to monitor resistance trends. This focus aids in informing treatment strategies and promoting prudent antibiotic usage. Additionally, the rise in infectious disease cases, fueled by elements such as increased travel, urbanization, and population growth, underscores the urgent need for efficient diagnosis and treatment options. Consequently, there is a heightened demand for effective and dependable AST solutions to combat the threats posed by resistant pathogens and ensure optimal patient care.

Restraints in the Antimicrobial Susceptibility Testing Market

In certain regions, particularly middle-income and low-income countries, there is a significant lack of awareness regarding the advantages of Antimicrobial Susceptibility Testing (AST). Additionally, inadequate training for laboratory personnel in the latest testing techniques can hinder the effective implementation of AST practices. Furthermore, the regulatory landscape concerning diagnostic instruments and solutions can be intricate and time-consuming, leading to challenges in the timely market introduction of innovative AST technologies. Stringent regulatory requirements may further exacerbate these delays, ultimately limiting the accessibility and utilization of essential AST methodologies in affected regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a notable trend toward the adoption of rapid testing techniques that significantly reduce the time needed to obtain results. Technologies such as mass spectrometry, molecular diagnostics, and automated systems are at the forefront of this transformation, enabling healthcare providers to swiftly identify pathogens and their susceptibility profiles. This advancement is particularly critical in urgent care scenarios, where timely interventions can greatly enhance patient outcomes. As healthcare environments increasingly prioritize efficiency and precision in treatment decisions, the demand for rapid testing solutions in antimicrobial susceptibility is expected to expand, driving innovation and investment in this sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Culture & Growth Media
  • Susceptibility Testing Disks
  • Mic Strips
  • Susceptibility Testing Plates
• Lab Instruments
  • Automated Laboratory Instruments
  • Molecular Diagnostics Systems
• Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Antibacterial Susceptibility Testing
• Antifungal Susceptibility Testing
• Antiparasitic Susceptibility Testing
• Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Qualitative Methods
  • Automated Ast
  • Disk Diffusion
  • Agar Dilution
  • Genotypic Method
• Quantitative Methods
  • ETEST Method
  • Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Epidemiology
• Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2026-2033)

• North America (Product, Type, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Type, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConvaTec Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiosis (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations